Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingResults10 Aug 2026

M & B Engineering Ltd

(A).Please note that the Board of Directors in their meeting held today have taken on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended on 30th June, ....

M & B Engineering Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has approved a brownfield expansion project for its Phenix Division. The company has also announced the date of its 44th Annual General Meeting, and has recommended the re-appointment of two directors and the appointment of a new cost auditor. Additionally, the company has allotted 12,503 equity shares under its employee stock option plan.

Read more →📎 1 attachment
BSECompany UpdateResults10 Aug 2026

Poly Medicure Ltd

ENCLOSED

Poly Medicure Ltd has published unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Jansatta, as per Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults10 Aug 2026

Kirloskar Brothers Ltd-$

Please find enclosed intimation under Regulation 30 of the SEBI Listing Regulations, 2015 pertaining to transcript of Analyst Meet.

Kirloskar Brothers Ltd. has announced its unaudited financial results for Q1 FY '27, with a 13% year-on-year growth in consolidated revenue to Rs.11,049 million. The company's consolidated EBITDA for the quarter stood at Rs.1,306 million, with a 2% year-on-year growth and an EBITDA margin of 11.8%. The company also recorded a 4% year-on-year growth in consolidated order intake to Rs.13,954 million.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults10 Aug 2026

Alembic Pharmaceuticals Ltd

Please find attached herewith the Transcript of Post Result Conference Call held on 4th August, 2026.

Alembic Pharmaceuticals Ltd reported a strong Q1 FY27 with 26% YoY revenue growth, driven by growth across all major businesses, including a 7% growth in India branded business, 37% growth in International Generics, and 33% growth in API business. The company's external environment remains competitive with pricing pressure, regulatory expectations, and geopolitical uncertainties.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults10 Aug 2026

M & B Engineering Limited

Outcome of Board Meeting

M & B Engineering Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved a brownfield expansion project for its Phenix Division. The company has also announced the re-appointment of two directors, the appointment of a new cost auditor, and the allotment of shares under its employee stock option plan.

Read more →📎 1 attachment
NSEUpdatesResults10 Aug 2026

Eastern Silk Industries Limited

Updates

Eastern Silk Industries Limited has informed the Exchange regarding the Revised Annual Report and the 80th Annual General Meeting (AGM) details, including the revised cut-off date and e-voting period.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults10 Aug 2026

Alembic Pharmaceuticals Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Alembic Pharmaceuticals Limited has reported a strong Q1 FY27 with 26% year-on-year revenue growth, driven by growth across all major businesses, including a 7% growth in India branded business, 37% growth in International Generics, and 33% growth in API business. The company has also strengthened its execution leadership with the appointment of Mr. Ramesh Juneja as Sales and Marketing Head for Human Health business.

Read more →📎 1 attachment
BSEBoard MeetingResults10 Aug 2026

Blue Cloud Softech Solutions Ltd

Blue Cloud Softech Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve The Un-Audited ....

Blue Cloud Softech Solutions Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults10 Aug 2026

Metropolis Healthcare Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Metropolis Healthcare Limited has informed the Exchange about the transcript of Q1 FY27 earnings conference call. The company's management discussed the Indian diagnostics industry's structural growth, the shift towards organized quality-led diagnostic providers, and the expanding role of molecular, genomic, and immunological testing.

Read more →📎 1 attachment
BSEBoard MeetingResults10 Aug 2026

HB Leasing & Finance Company Ltd

Outcome of the Board meeting held on 10th August, 2026

HB Leasing & Finance Company Ltd has announced the outcome of its board meeting held on 10th August, 2026, where the board considered and approved the unaudited financial results for the quarter ended 30th June, 2026. The company has attached a copy of the unaudited financial results along with the limited review report issued by the statutory auditors, M/s N.C. Aggarwal & Co.

Read more →📎 1 attachment
← PreviousPage 833 of 2040Next →